Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LTRN

LTRN News

Newswire

09:25

Lantern Pharma Reports Positive Phase 1a Data for LP-184 in Advanced Solid Tumors.

08:36

Lantern Pharma Announces Positive LP-184 Phase 1a Results, Advancing Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials

20:35

Lantern Pharma Discusses LP-184 Phase 1a Clinical Results and Implications for DNA Damage Repair-Deficient Tumors

08:36

Lantern Pharma Reports Q3 2025 Financial Results and Business Updates

16:04

Lantern Pharma shares surge 15.79% after-hours as CEO highlights AI-driven drug discovery advancements.

View More

About LTRN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More